Study Links Anemia Drugs To Increased Mortality Risk

Law360, New York (February 28, 2008, 12:00 AM EST) -- A group of drugs used to treat anemia in cancer patients undergoing chemotherapy has again been linked to a greater risk of blood clots and death, this time by a study published in the Journal of the American Medical Association.

The study, an analysis of more than 50 separate clinical trials, concluded that patients using so-called erythropoiesis-stimulating agents or ESAs raised their mortality risk by 10%. The study's authors said their findings raised concerns about the safety of prescribing ESAs to cancer patients.

“It looks pretty...
To view the full article, register now.